Caledonian Cachexia Collaborative

Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer

M. Stares, M. Mackean, C. Barrie, 2023, Cancers.